Faculty Opinions recommendation of The hexosamine biosynthesis pathway is a targetable liability in KRAS/LKB1 mutant lung cancer.
2007 ◽
Vol 27
(16)
◽
pp. 5849-5859
◽
2013 ◽
Vol 03
(04)
◽
pp. 1-8
◽